[ Price : $8.95]
FDA posts a final guidance entitled Reporting Amount of Listed Drugs and Biological Products Technical Conformance Guide.[ Price : $8.95]
FDA India director Sarah McMullen says the agency is working to increase drug inspections in India and station additional investig...[ Price : $8.95]
Viking Therapeutics says its Phase 2 clinical trial of obesity drug VK2735, a dual agonist of glucagon-like peptide 1 and glucose-...[ Price : $8.95]
FDA issues a safety alert advising patients and healthcare providers about the potential risk of serious complications with Holigi...[ Price : $8.95]
FDA researchers say a wide range of treatments for rare pediatric diseases have been developed in the 10 years since the pediatric...[ Price : $8.95]
FDA accepts for review a BeiGene BLA for Tevimbra (tislelizumab) for combination use with chemotherapy in treating locally advance...[ Price : $8.95]
FDA sends Minerva Neurosciences a complete response letter on its NDA for roluperidone, indicated for treating negative symptoms i...[ Price : $8.95]
Former FDA associate chief counsel and CDER policy advisor Eva A. Temkin joins Paul Hastings as chair of the firms FDA practice.